ABCL - AbCellera Biologics Inc.

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 2.4

Open

$ 2.41

Bid

$ 2.40 x 4,584

Ask

$ 2.41 x 3,200

Day's Range

$ 2.37 - $ 2.53

52 Week Range

$ 2.36 - $ 6.06

Volume

2,215,821

Average Volume

Market Cap

707.2M

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-20-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-21-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	02-25-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-13-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

this-globant-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Globant Analyst Is No Longer Bullish;...
08/20/2024 13:45:15

Benchmark Downgrades AbCellera Biologics t...
08/20/2024 11:40:39

Benchmark analyst Robert Wasserman downgrades AbCellera Biologics (NASDAQ:ABCL) from Buy to Hold.

AbCellera Biologics Q2 EPS $(0.13) Beats $...
08/06/2024 20:07:02

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $...

AbCellera And Lilly Expand Collaboration T...
07/31/2024 13:11:47

AbCellera (NASDAQ:ABCL) announced today that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to d...

Keybanc Maintains Overweight on AbCellera ...
07/11/2024 11:20:47

Keybanc analyst Scott Schoenhaus maintains AbCellera Biologics (NASDAQ:ABCL) with a Overweight and lowers the price target f...

Keybanc Maintains Overweight on AbCellera ...
05/08/2024 18:18:45

Keybanc analyst Scott Schoenhaus maintains AbCellera Biologics (NASDAQ:ABCL) with a Overweight and lowers the price target f...

AbCellera Biologics Q1 2024 GAAP EPS $(0.1...
05/07/2024 20:13:40

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $...

AbCellera Presents Data On T-Cell Engagers...
04/08/2024 16:06:31

Data show how AbCellera is expanding the reach of T-cell engagers with:CD3-binding antibodies that consistently generate T-cell...

AbCellera To Collaborate With Biogen To Di...
03/11/2024 13:03:20

AbCellera (NASDAQ:ABCL) and Biogen Inc. (NASDAQ:BIIB) have entered into a strategic collaboration to discover antibodies for a ...

Benchmark Upgrades AbCellera Biologics to Buy
02/22/2024 12:05:17

Benchmark analyst Robert Wasserman upgrades AbCellera Biologics (NASDAQ:ABCL) from Hold to Buy.

Recap: AbCellera Biologics Q4 Earnings
02/20/2024 21:30:41

AbCellera Biologics Q4 2023 GAAP EPS $(0.1...
02/20/2024 21:26:02

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of...

Earnings Scheduled For February 20, 2024
02/20/2024 11:52:12

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

Keybanc Initiates Coverage On AbCellera Bi...
12/05/2023 11:03:00

Keybanc analyst Scott Schoenhaus initiates coverage on AbCellera Biologics (NASDAQ:ABCL) with a Overweight rating and announ...

AbCellera Presents New Data On Two T-Cell ...
11/03/2023 16:07:22

New data from AbCellera's T-cell engager platform demonstrates that diverse CD3-binding antibodies enable optimization of T...

AbCellera shares are trading lower after t...
11/03/2023 13:22:21

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
11/03/2023 13:05:47

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
11/02/2023 21:31:11

AbCellera Biologics Q3 EPS $(0.10) Beats $...
11/02/2023 20:25:28

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $...

Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...